Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 8 studies | 39% ± 22% | |
| granule cell | 4 studies | 30% ± 7% | |
| GABAergic neuron | 4 studies | 41% ± 16% | |
| endothelial cell | 3 studies | 33% ± 6% | |
| interneuron | 3 studies | 42% ± 24% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 31% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 96% | 15380.99 | 2532 / 2642 | 99% | 9.47 | 700 / 705 |
| kidney | 87% | 1659.92 | 77 / 89 | 69% | 7.24 | 623 / 901 |
| skin | 61% | 738.89 | 1099 / 1809 | 71% | 2.90 | 333 / 472 |
| uterus | 55% | 607.96 | 94 / 170 | 72% | 5.18 | 331 / 459 |
| muscle | 99% | 3482.85 | 793 / 803 | 0% | 0 | 0 / 0 |
| ovary | 20% | 221.40 | 36 / 180 | 74% | 2.92 | 319 / 430 |
| heart | 93% | 2976.56 | 804 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 78% | 1.93 | 35 / 45 |
| lung | 17% | 134.65 | 96 / 578 | 59% | 2.37 | 680 / 1155 |
| esophagus | 33% | 328.53 | 473 / 1445 | 34% | 1.06 | 62 / 183 |
| breast | 16% | 147.86 | 74 / 459 | 47% | 1.68 | 521 / 1118 |
| blood vessel | 58% | 856.70 | 770 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 2% | 49.76 | 4 / 258 | 55% | 2.14 | 127 / 230 |
| spleen | 52% | 645.18 | 125 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 50% | 1.06 | 40 / 80 |
| bladder | 10% | 53.14 | 2 / 21 | 37% | 1.24 | 185 / 504 |
| intestine | 31% | 289.57 | 300 / 966 | 14% | 0.30 | 73 / 527 |
| thymus | 7% | 47.11 | 47 / 653 | 32% | 0.57 | 194 / 605 |
| prostate | 25% | 261.00 | 61 / 245 | 7% | 0.19 | 37 / 502 |
| stomach | 18% | 195.26 | 65 / 359 | 14% | 0.30 | 39 / 286 |
| pancreas | 0% | 0 | 0 / 328 | 30% | 0.80 | 53 / 178 |
| peripheral blood | 18% | 645.03 | 170 / 929 | 0% | 0 | 0 / 0 |
| liver | 2% | 26.18 | 5 / 226 | 9% | 0.24 | 35 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.14 | 3 / 29 |
| adipose | 5% | 70.78 | 66 / 1204 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0050808 | Biological process | synapse organization |
| GO_0009986 | Cellular component | cell surface |
| GO_0048786 | Cellular component | presynaptic active zone |
| GO_0005829 | Cellular component | cytosol |
| GO_0045202 | Cellular component | synapse |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PPFIA4 |
| Protein name | Liprin-alpha-4 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4) (PTPRF-interacting protein alpha-4) PTPRF interacting protein alpha 4 |
| Synonyms | KIAA0897 |
| Description | FUNCTION: May regulate the disassembly of focal adhesions. May localize receptor-like tyrosine phosphatases type 2A at specific sites on the plasma membrane, possibly regulating their interaction with the extracellular environment and their association with substrates (By similarity). . |
| Accessions | ENST00000367240.6 ENST00000600426.5 O75335 ENST00000692772.1 M0R219 ENST00000599966.5 [O75335-2] A0A8J8YUZ5 M0QZB5 ENST00000599514.1 ENST00000295706.9 B1APN9 ENST00000447715.6 [O75335-3] ENST00000272198.10 [O75335-1] A0A8I5QJ45 |
